Home|Journals|Articles by Year|Audio Abstracts
 

Review Article

Open Vet J. 2019; 9(4): 349-360


Virus-induced immunosuppression in turkeys (Meleagris gallopavo): A review

Khaled KABOUDI.




Abstract
Cited by 7 Articles

Immunosuppression is characterized by a dysfunction of humoral and/or cellular immune response leading to increase of susceptibility secondary infection, increase of mortality and morbidity, poor productivity and welfare and vaccination failures. Humoral immune response depression is due to perturbation of soluble factors, as complement and chemokines in innate immunity and antibodies or cytokines in adaptive immunity. At the cellular immune response, immunosuppression is the consequence of the dysfunction of T-cells, B-cells, heterophils, monocytes, macrophages and natural Killer cells. Immunosuppression in turkeys can be caused by numerous, non-infectious and infectious agents, having variable pathological and molecular mechanisms. Interactions between them are very complex. This paper reviews the common viruses inducing clinical and sub-clinical immunosuppression in turkeys, and enteric and neoplastic viruses in particular, as well as the interactions among them. Evaluation of immunosuppression is currently based on classical approach, however new technique such as the microarray technology is being developed to investigate immunological mediator’s genes detection. Controlling of immunosuppression include, in general, biosecurity practices, maintaining appropriate breeding conditions and vaccination of breeders and their progeny. Nevertheless, few vaccines are available against immunosuppressive viruses in turkey’s industry. The development of new control strategies is reviewed.

Key words: cellular immunity, humoral immunity, immunosuppression, lymphocyte, turkey






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.